RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 2002; 88(01): 157-158
DOI: 10.1055/s-0037-1613170
DOI: 10.1055/s-0037-1613170
Scientific and Standardization Committee Communications
Recommendations for tPA Thrombolysis in Children
On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and HaemostasisWeitere Informationen
Publikationsverlauf
Received
15. April 2002
Accepted
15. April 2002
Publikationsdatum:
09. Dezember 2017 (online)

-
References
- 1 Levy M, Benson LN, Burrows PE, Bentur Y, Strong DK, Smith J, Johnson D, Jacobson S, Koren G. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991; 118: 467-72.
- 2 Farnoux C, Camard O, Pinquier D, Hurtaud-Roux M-F, Sebag G, Schlegel N, Beaufils F. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr 1997; 133: 137-40.
- 3 Weiner GM, Castle V, DiPietro MA, Faix RG. Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator. J Pediatr 1998; 133: 133-6.
- 4 Haire WD, Atkinson JB, Stephens LC, Kotulak GD. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial. Thromb Haemost 1994; 72: 543-7.
- 5 Davis SN, Vermeulen L, Banton J, Schwartz BS, Williams EC. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices. Am J Health-Sys Pharm 2000; 57: 1039-45.